1 code implementation • 28 Jul 2023 • Anthony Brohan, Noah Brown, Justice Carbajal, Yevgen Chebotar, Xi Chen, Krzysztof Choromanski, Tianli Ding, Danny Driess, Avinava Dubey, Chelsea Finn, Pete Florence, Chuyuan Fu, Montse Gonzalez Arenas, Keerthana Gopalakrishnan, Kehang Han, Karol Hausman, Alexander Herzog, Jasmine Hsu, Brian Ichter, Alex Irpan, Nikhil Joshi, Ryan Julian, Dmitry Kalashnikov, Yuheng Kuang, Isabel Leal, Lisa Lee, Tsang-Wei Edward Lee, Sergey Levine, Yao Lu, Henryk Michalewski, Igor Mordatch, Karl Pertsch, Kanishka Rao, Krista Reymann, Michael Ryoo, Grecia Salazar, Pannag Sanketi, Pierre Sermanet, Jaspiar Singh, Anikait Singh, Radu Soricut, Huong Tran, Vincent Vanhoucke, Quan Vuong, Ayzaan Wahid, Stefan Welker, Paul Wohlhart, Jialin Wu, Fei Xia, Ted Xiao, Peng Xu, Sichun Xu, Tianhe Yu, Brianna Zitkovich
Our goal is to enable a single end-to-end trained model to both learn to map robot observations to actions and enjoy the benefits of large-scale pretraining on language and vision-language data from the web.
1 code implementation • 15 Jul 2022 • Dustin Tran, Jeremiah Liu, Michael W. Dusenberry, Du Phan, Mark Collier, Jie Ren, Kehang Han, Zi Wang, Zelda Mariet, Huiyi Hu, Neil Band, Tim G. J. Rudner, Karan Singhal, Zachary Nado, Joost van Amersfoort, Andreas Kirsch, Rodolphe Jenatton, Nithum Thain, Honglin Yuan, Kelly Buchanan, Kevin Murphy, D. Sculley, Yarin Gal, Zoubin Ghahramani, Jasper Snoek, Balaji Lakshminarayanan
A recent trend in artificial intelligence is the use of pretrained models for language and vision tasks, which have achieved extraordinary performance but also puzzling failures.
no code implementations • 25 Nov 2021 • Kehang Han, Balaji Lakshminarayanan, Jeremiah Liu
The concern of overconfident mis-predictions under distributional shift demands extensive reliability research on Graph Neural Networks used in critical tasks in drug discovery.
no code implementations • NeurIPS Workshop AI4Scien 2021 • Kehang Han, Steven Kearnes, Jin Xu, Wen Torng, JW Feng
DNA-Encoded Libraries (DEL thereafter) data, often with millions of data points, enables large deep learning models to make real contributions in the drug discovery process (e. g., hit-finding).